Stage III Major Salivary Gland Carcinoma
1 clinical trials · Condition
◉ Watch Stage III Major Salivary Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510) | University of Washington | 2015-10-08 |
Track Stage III Major Salivary Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.